[
  {
    "ts": "2025-09-09T15:34:00+00:00",
    "headline": "LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal",
    "summary": "Lilly's Jaypirca shows a strong survival benefit over chemoimmunotherapy in treatment-naive CLL/SLL, boosting its potential in front-line use.",
    "url": "https://finance.yahoo.com/news/llys-phase-iii-study-jaypirca-153400257.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "2f4ed4d2-56f4-396c-b1a5-a060679819dc",
      "content": {
        "id": "2f4ed4d2-56f4-396c-b1a5-a060679819dc",
        "contentType": "STORY",
        "title": "LLY's Phase III Study on Jaypirca in Front-Line Leukemia Meets Goal",
        "description": "",
        "summary": "Lilly's Jaypirca shows a strong survival benefit over chemoimmunotherapy in treatment-naive CLL/SLL, boosting its potential in front-line use.",
        "pubDate": "2025-09-09T15:34:00Z",
        "displayTime": "2025-09-09T15:34:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MjuR.4zEKm0FgKsxK.lBKQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.VCDKzJSEg_sv.1sSAJrQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/60c096e1e24bb285c41a58d325d8d707.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/llys-phase-iii-study-jaypirca-153400257.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/llys-phase-iii-study-jaypirca-153400257.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "LLY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-09-09T12:00:00+00:00",
    "headline": "BOTOX® Cosmetic (onabotulinumtoxinA) Unveils \"The One & Only\" Campaign Featuring Real People and Their Distinctive Stories",
    "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced a new chapter for BOTOX® Cosmetic with the debut of \"The One & Only\" campaign, a national, multichannel marketing initiative that champions self-expression and individuality. The one and only brand to do it first, BOTOX® Cosmetic is the #1 selling neurotoxin worldwide with the most FDA-approved aesthetic indication areas in the category, empowering patients to embrace the one and only version of themselves.2,4-9",
    "url": "https://finance.yahoo.com/news/botox-cosmetic-onabotulinumtoxina-unveils-one-120000597.html",
    "source": "PR Newswire",
    "provider": "yfinance",
    "raw": {
      "id": "ada3cb7b-cb45-3e9a-b060-bc5fc197d99e",
      "content": {
        "id": "ada3cb7b-cb45-3e9a-b060-bc5fc197d99e",
        "contentType": "STORY",
        "title": "BOTOX® Cosmetic (onabotulinumtoxinA) Unveils \"The One & Only\" Campaign Featuring Real People and Their Distinctive Stories",
        "description": "",
        "summary": "Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced a new chapter for BOTOX® Cosmetic with the debut of \"The One & Only\" campaign, a national, multichannel marketing initiative that champions self-expression and individuality. The one and only brand to do it first, BOTOX® Cosmetic is the #1 selling neurotoxin worldwide with the most FDA-approved aesthetic indication areas in the category, empowering patients to embrace the one and only version of themselves.2,4-9",
        "pubDate": "2025-09-09T12:00:00Z",
        "displayTime": "2025-09-09T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/prnewswire.com/aceb97f47294fc7182fff6b54c9e2c62",
          "originalWidth": 400,
          "originalHeight": 225,
          "caption": "“The One & Only” Campaign is BOTOX Cosmetic’s (onabotulinumtoxinA) largest ever, appearing across linear and connected TV, digital, social, and out-of-home. Image features real patients. Results may vary.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pNx_oIlt4Y7rFDMtf6CHAg--~B/aD0yMjU7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/aceb97f47294fc7182fff6b54c9e2c62.cf.webp",
              "width": 400,
              "height": 225,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AOXbRKR6hMjrpUMXik3yoA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/prnewswire.com/aceb97f47294fc7182fff6b54c9e2c62.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "PR Newswire",
          "url": "https://www.prnewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/botox-cosmetic-onabotulinumtoxina-unveils-one-120000597.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/botox-cosmetic-onabotulinumtoxina-unveils-one-120000597.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]